BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22985881)

  • 21. Uptake, Stability, and Activity of Antisense Anti-
    Yavari N; Goltermann L; Nielsen PE
    ACS Chem Biol; 2021 Mar; 16(3):471-479. PubMed ID: 33684286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
    Deere J; Iversen P; Geller BL
    Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence specificity defines the effectiveness of PPMOs targeting
    Nanayakkara AK; Moustafa DA; Pifer R; Goldberg JB; Greenberg DE
    Antimicrob Agents Chemother; 2023 Sep; 67(9):e0024523. PubMed ID: 37610213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
    Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect.
    Nikravesh A; Dryselius R; Faridani OR; Goh S; Sadeghizadeh M; Behmanesh M; Ganyu A; Klok EJ; Zain R; Good L
    Mol Ther; 2007 Aug; 15(8):1537-42. PubMed ID: 17534267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and structural study of the dimeric inner membrane protein SbmA.
    Corbalan N; Runti G; Adler C; Covaceuszach S; Ford RC; Lamba D; Beis K; Scocchi M; Vincent PA
    J Bacteriol; 2013 Dec; 195(23):5352-61. PubMed ID: 24078611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection.
    Daly SM; Sturge CR; Marshall-Batty KR; Felder-Scott CF; Jain R; Geller BL; Greenberg DE
    ACS Infect Dis; 2018 May; 4(5):806-814. PubMed ID: 29461800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of sbmA and tolC mutations in Escherichia coli K-12 Tn10-carrying strains results in hypersusceptibility to tetracycline.
    de Cristóbal RE; Vincent PA; Salomón RA
    J Bacteriol; 2008 Feb; 190(4):1491-4. PubMed ID: 18083810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.
    Cansizoglu MF; Toprak E
    Curr Genet; 2017 Dec; 63(6):973-976. PubMed ID: 28497241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity spectrum of colicins produced by Shigella sonnei and genetic mechanism of colicin resistance in conspecific S. sonnei strains and Escherichia coli.
    Calcuttawala F; Hariharan C; Pazhani GP; Ghosh S; Ramamurthy T
    Antimicrob Agents Chemother; 2015 Jan; 59(1):152-8. PubMed ID: 25331695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.
    Hein-Kristensen L; Franzyk H; Holch A; Gram L
    PLoS One; 2013; 8(9):e73620. PubMed ID: 24040003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An alternative strategy to increasing influenza virus replication for vaccine production in chicken embryo fibroblast (DF-1) cells by inhibiting interferon alpha and beta using peptide-conjugated phosphorodiamidate morpholino oligomers.
    Prescott MA; Moulton H; Pastey MK
    J Med Microbiol; 2024 Feb; 73(2):. PubMed ID: 38353513
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides.
    Mattiuzzo M; Bandiera A; Gennaro R; Benincasa M; Pacor S; Antcheva N; Scocchi M
    Mol Microbiol; 2007 Oct; 66(1):151-63. PubMed ID: 17725560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The conserved modular elements of the acyl carrier proteins of lipid synthesis are only partially interchangeable.
    Zhu L; Cronan JE
    J Biol Chem; 2015 May; 290(22):13791-9. PubMed ID: 25861991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37.
    Chung MC; Dean SN; van Hoek ML
    Biochem J; 2015 Sep; 470(2):243-53. PubMed ID: 26188040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
    Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.
    Tran T; Ran Q; Ostrer L; Khodursky A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6353-5. PubMed ID: 27431218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
    Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
    Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic-free bacterial strain selection using antisense peptide nucleic acid.
    Dryselius R; Nekhotiaeva N; Nielsen PE; Good L
    Biotechniques; 2003 Nov; 35(5):1060-4. PubMed ID: 14628680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
    Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
    J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.